Ken Hunt is the kind of corporate hired gun who specializes in showing companies how to operate more efficiently and increase their bottom line. A management consultant based in Chicago...

Glioblastoma is a virtually incurable brain cancer with a five-year-survival rate of only 10%.    “It’s heartbreaking to keep telling people in clinic that we don’t have a cure,” said...

Pediatric sarcomas, which affect the bones and soft tissues of children and teenagers, are among the toughest cancers to treat. Pediatric oncologist Janet Yoon, M.D., is passionately dedicated to...

Behnam Badie, M.D.City of Hope’s Brain Tumor Program is constantly looking at ways to improve care in the field of neurological cancers by combining innovative research with expert...

Roughly 15-20% of people diagnosed with colorectal cancer (CRC), the third most common cancer diagnosed in both sexes in the U.S., excluding skin cancer, will have tumors with deficient mismatch...

Laleh Melstrom, M.D., M.S.Remote Perioperative Telemonitoring of Patient-generated Physiologic Health Data and Patient-reported Outcomes Patient-generated health data (PGHD) and patient-reported outcomes (PROs) are increasingly being used in...

Prostate cancer cells Internationally recognized prostate cancer researcher and associate professor of medicine in the Department of Medical Oncology & Therapeutics Research, Tanya Dorff, M.D., has focused heavily on...

Marwan G. Fakih, M.D.Phase 1 Trial of Sotorasib (AMG 510) in Advanced, Heavily Pretreated Solid Tumors Kirsten rat sarcoma viral oncogene homolog (KRAS), the most frequently mutated oncogene...

Sanjeet S. Dadwal, M.D. City of Hope researchers, led by Don Diamond, Ph.D., who developed COH04S1 vaccine against SARS-CoV2, and Sanjeet S. Dadwal, M.D., principal investigator for the...

The physician-scientists at City of Hope who see one of the highest volumes of patients with multiple myeloma in Southern California have firsthand knowledge of the unmet treatment needs...